Toremifene citrate (Fareston).
Gerken
Patty
P
Kansas City Cancer Center-South, Missouri, USA.
D018931:Antineoplastic Agents, Hormonal / Q000494:pharmacology / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000451:nursing; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008875:Middle Aged; D024802:Nurse's Role; D009859:Oncology Nursing / Q000379:methods; D010353:Patient Education as Topic; D018579:Patient Selection; D017698:Postmenopause; D020845:Selective Estrogen Receptor Modulators / Q000494:pharmacology / Q000627:therapeutic use*; D017312:Toremifene / Q000494:pharmacology / Q000627:therapeutic use*; D016896:Treatment Outcome
D018931:Antineoplastic Agents, Hormonal; D020845:Selective Estrogen Receptor Modulators; D017312:Toremifene